跳至主要内容
临床试验/JPRN-C000000315
JPRN-C000000315已完成未知

EFFECTS of BLOOD PRESSURE LOWERING and ANTIHYPERTENSIVE DRUG CLASS on SURVIVAL and CARDIOVASCULAR EVENTS of HEMODIALYSIS PATIENTS: - Hemodialysis Heart Angiotensin-Inhibition Rescue Trial (HHEART) Randomized Clinical Trial

Div. Nephrology, GenGen-Do Kimitsu Hospital0 个研究点目标入组 400 人开始时间: 2006年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
23years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • patients with preserved residual renal function (urine volume of more than 500 mL per day), pre-dialysis BP of less than 140/60 mm Hg, unstable homodynamic during hemodialysis therapy, a history of drug-allergy, accelerated or malignant hypertension within six months, secondary hypertension, severe systemic diseases, including cardio-,cerebro- and peripheral vascular, pulmonary, and gastrointestinal and hepatic diseases.

研究者

发起方
Div. Nephrology, GenGen-Do Kimitsu Hospital

相似试验